株探米国株
日本語 英語
エドガーで原本を確認する
0001670541FALSE00016705412026-05-062026-05-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): May 6, 2026

ADIENT PLC
(Exact name of registrant as specified in its charter)

Ireland 001-37757 98-1328821
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number)
 25 North Wall Quay
Dublin 1, Ireland D01 H104
(Address of principal executive offices)

Registrant’s telephone number, including area code: 734-254-5000

Not applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of class Trading symbol(s) Name of exchange on which registered
Ordinary Shares, par value $0.001 ADNT New York Stock Exchange


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrants under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17     CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐










































Item 2.02 Results of Operations and Financial Condition.

On May 6, 2026, Adient plc (the “Company”) issued a news release announcing its financial results for the second quarter ended March 31, 2026. The news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

The information contained in Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.
EXHIBIT INDEX
Exhibit No. Exhibit Description
99.1
104
Cover Page Interactive Data File (the Cover Page Interactive Data File is embedded within the Inline XBRL document).





SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADIENT PLC
Date: May 6, 2026
By: /s/ Heather M. Tiltmann
Name: Heather M. Tiltmann
Title:
Executive Vice President, Chief Legal and Human Resources Officer, and Corporate Secretary


EX-99.1 2 a050620268kexhibit991.htm EX-99.1 Document
Exhibit 99.1
q2fy26-earningsinfographicb.jpg




q2fy26-earningsinfographicc.jpg




q2fy26-earningsinfographic.jpg



q2fy26-earningsinfographica.jpg


Appendix
Page 1

Adient plc
Condensed Consolidated Statements of Income (Loss)
(Unaudited)
Three Months Ended
March 31,
(in millions, except per share data) 2026 2025
Net sales $ 3,865  $ 3,611 
Cost of sales 3,608  3,350 
Gross profit 257  261 
Selling, general and administrative expenses 138  144 
Restructuring and impairment costs 351 
Equity income 13  18 
Earnings (loss) before interest and income taxes 127  (216)
Net financing charges 48  48 
Other pension expense
Income (loss) before income taxes 76  (265)
Income tax provision 32  48 
Net income (loss) 44  (313)
Income attributable to noncontrolling interests 17  22 
Net income (loss) attributable to Adient $ 27  $ (335)
Diluted earnings (loss) per share $ 0.34  $ (3.99)
Shares outstanding at period end 78.4  84.0 
Diluted weighted average shares 79.3  84.0 



Appendix
Page 2

Adient plc
Condensed Consolidated Statements of Financial Position
(Unaudited)

March 31, September 30,
(in millions) 2026 2025
Assets
Cash and cash equivalents $ 831  $ 958 
Accounts receivable - net
2,032  1,873 
Inventories 735  695 
Other current assets 649  607 
Current assets 4,247  4,133 
Property, plant and equipment - net 1,384  1,409 
Goodwill 1,798  1,807 
Other intangible assets - net 305  319 
Investments in partially-owned affiliates 301  276 
Assets held for sale 12 
Other noncurrent assets 985  1,001 
Total assets $ 9,032  $ 8,954 
Liabilities and Shareholders' Equity
Short-term debt $ $ 11 
Accounts payable and accrued expenses 3,113  2,942 
Other current liabilities 748  734 
Current liabilities 3,870  3,687 
Long-term debt 2,379  2,386 
Other noncurrent liabilities 695  723 
Redeemable noncontrolling interests 71  95 
Shareholders' equity attributable to Adient 1,713  1,766 
Noncontrolling interests 304  297 
Total liabilities and shareholders' equity $ 9,032  $ 8,954 




Appendix
Page 3

Adient plc
Condensed Consolidated Statements of Cash Flows
(Unaudited)
Three Months Ended
March 31,
(in millions) 2026 2025
Operating Activities
Net income (loss) attributable to Adient $ 27  $ (335)
Income attributable to noncontrolling interests 17  22 
Net income (loss) 44  (313)
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:
Depreciation 68  67 
Amortization of intangibles 12  12 
Pension and postretirement benefit expense
Pension and postretirement contributions, net (8) (5)
Equity in earnings of partially-owned affiliates, net of dividends received 15  29 
Deferred income taxes 10 
Non-cash impairment charges —  333 
Equity-based compensation
Other
Changes in assets and liabilities:
Receivables (411) (439)
Inventories 17  18 
Other assets 15  (5)
Accounts payable and accrued liabilities 336  223 
Accrued income taxes (23) 12 
Cash provided (used) by operating activities 81  (45)
Investing Activities
Capital expenditures (73) (45)
Sale of property, plant and equipment — 
Investments in partially-owned affiliates (2) — 
Other —  (1)
Cash used by investing activities (75) (44)
Financing Activities
Drawdown of ABL revolver and other bank borrowings 150 
Repayment of ABL revolver and other bank borrowings (152) — 
Issuance of long-term debt —  795 
(Repayment) of long-term debt (3) (797)
Debt financing costs (1) (12)
Dividends paid to noncontrolling interests (1) (35)
Cash used by financing activities (7) (47)
Effect of exchange rate changes on cash and cash equivalents (23) 30 
Decrease in cash and cash equivalents $ (24) $ (106)


Appendix
Page 4

Footnotes


1. Segment Results

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income (loss) before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items. Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

Financial information relating to Adient's reportable segments is as follows:

(in millions) Three months ended March 31, 2026
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 1,884  $ 1,272  $ 734  $ (25) $ 3,865 
Adjusted EBITDA $ 109  $ 45  $ 92  $ (23) $ 223 
Adjusted EBITDA margin 5.8  % 3.5  % 12.5  % N/A 5.8  %
Three months ended March 31, 2025
Americas EMEA Asia Corporate/Eliminations Consolidated
Net sales $ 1,699  $ 1,231  $ 707  $ (26) $ 3,611 
Adjusted EBITDA $ 94  $ 50  $ 110  $ (21) $ 233 
Adjusted EBITDA margin 5.5  % 4.1  % 15.6  % N/A 6.5  %


Appendix
Page 5

The following is a reconciliation of Adient's reportable segments' adjusted EBITDA to income (loss) before income taxes:

Three Months Ended
March 31,
(in millions) 2026 2025
Adjusted EBITDA
Americas $ 109  $ 94 
EMEA 45  50 
Asia 92  110 
Subtotal 246  254 
Corporate-related costs (1)
(23) (21)
Restructuring and impairment costs (2)
(5) (351)
Purchase accounting amortization (3)
(12) (12)
Restructuring related activities (4)
(6) (5)
Equity based compensation (9) (5)
Depreciation (68) (67)
Other items (5)
(9)
Earnings (loss) before interest and income taxes $ 127  $ (216)
Net financing charges (48) (48)
Other pension expense (3) (1)
Income (loss) before income taxes $ 76  $ (265)

Refer to the Footnote Addendum for footnote explanations.


2. Earnings (loss) Per Share

The following table reconciles the numerators and denominators used to calculate basic and diluted income (loss) per share:

Three Months Ended
March 31,
(in millions, except per share data) 2026 2025
Income available to shareholders
Net income (loss) attributable to Adient $ 27  $ (335)
Weighted average shares outstanding
Basic weighted average shares outstanding 78.4  84.0 
Effect of dilutive securities:
Unvested restricted stock and unvested performance share awards 0.9  — 
Diluted weighted average shares outstanding 79.3  84.0 
Earnings (loss) per share:
Basic $ 0.34  $ (3.99)
Diluted $ 0.34  $ (3.99)

The effect of common stock equivalents which would have been anti-dilutive was excluded, and immaterial, from the calculation of diluted earnings per share for the three months ended March 31, 2026. Potentially dilutive securities whose effect would have been anti-dilutive are excluded from the computation of diluted earnings per share for the three months ended March 31, 2025 as a result of being in a loss position.


Appendix
Page 6

3. Non-GAAP Measures

Adjusted EBIT, adjusted EBIT margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income (loss) attributable to Adient, adjusted effective tax rate, adjusted earnings per share, adjusted equity income, adjusted interest expense, free cash flow, net debt, and net leverage ratio as well as other measures presented on an adjusted basis are not recognized terms under U.S. GAAP and do not purport to be alternatives to the most comparable U.S. GAAP amounts. Since all companies do not use identical calculations, our definition and presentation of these measures may not be comparable to similarly titled measures reported by other companies. Management uses the identified non-GAAP measures to evaluate the operating performance of Adient and its business segments and to forecast future periods. Management believes these non-GAAP measures assist investors and other interested parties in evaluating Adient's on-going operations and provide important supplemental information to management and investors regarding financial and business trends relating to Adient's financial condition and results of operations. Investors should not consider these non-GAAP measures as alternatives to the related GAAP measures. Reconciliations of non-GAAP measures to their closest U.S. GAAP equivalent are presented in the corresponding tables that follow the definitions below. Reconciliations of non-GAAP measures related to guidance for any future period have not been provided due to the unreasonable efforts it would take to provide such reconciliations.

Table
(a) Adjusted EBIT is defined as earnings (loss) before income taxes and noncontrolling interests excluding net financing charges, restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, and net mark-to-market adjustments on pension and postretirement plans. Adjusted EBIT margin is adjusted EBIT as a percentage of net sales.
(b) Adjusted EBITDA is defined as adjusted EBIT excluding depreciation and equity based compensation. Certain corporate-related costs are not allocated to the business segments in determining adjusted EBITDA. Adjusted EBITDA margin is adjusted EBITDA as a percentage of net sales.
(c) Adjusted net income attributable to Adient is defined as net income (loss) attributable to Adient excluding restructuring, impairment and related costs, purchase accounting amortization, transaction gains/losses, other significant non-recurring items, net mark-to-market adjustments on pension and postretirement plans, the tax impact of these items and other discrete tax charges/benefits.
(d) Adjusted income tax expense is defined as income tax expense adjusted for the tax effect of the adjustments to income before income taxes and other discrete tax changes/benefits. Adjusted effective tax rate is defined as adjusted income tax provision as a percentage of adjusted income before income taxes.
(e) Adjusted diluted earnings per share is defined as adjusted net income attributable to Adient divided by diluted weighted average shares.
(f) Adjusted equity income is defined as equity income excluding amortization of Adient's intangible assets related to its non-consolidated joint ventures and other unusual or non-recurring items impacting equity income.
(g) Adjusted interest expense is defined as net financing charges excluding unusual or one-time items impacting interest expense.
(h) Free cash flow is defined as cash provided by operating activities less capital expenditures.
(i) Net debt is calculated as total debt (short-term and long-term) less cash and cash equivalents.
(j) Net leverage ratio is calculated as net debt divided by adjusted EBITDA for the last four quarters.







Appendix
Page 7

Reconciliations of non-GAAP measures to their closest US GAAP equivalent:


(a) & (b) Adjusted EBIT and Adjusted EBITDA

The following table reconciles net income (loss) to EBIT, adjusted EBIT and adjusted EBITDA:

Three Months Ended
March 31,
(in millions) 2026 2025
Net income (loss) $ 44  $ (313)
Net financing charges 48  48 
Other pension expense
Income tax expense 32  48 
Earnings (loss) before interest and income taxes (EBIT) $ 127  $ (216)
EBIT adjustments:
Restructuring and impairment costs (2)
351 
Purchase accounting amortization (3)
12  12 
Restructuring related activities (4)
Other items (5)
(4)
EBIT adjustments total 19  377 
Adjusted EBIT $ 146  $ 161 
EBITDA adjustments:
Depreciation 68  67 
Equity based compensation
Adjusted EBITDA $ 223  $ 233 
Net sales $ 3,865  $ 3,611 
Net income (loss) as % of net sales 1.1  % (8.7) %
EBIT as % of net sales 3.3  % (6.0) %
Adjusted EBIT as % of net sales 3.8  % 4.5  %
Adjusted EBITDA as % of net sales 5.8  % 6.5  %

Refer to the Footnote Addendum for footnote explanations.



Appendix
Page 8


(c) Adjusted net income attributable to Adient

The following table reconciles net income (loss) attributable to Adient to adjusted net income attributable to Adient:

Three Months Ended
March 31,
(in millions) 2026 2025
Net income (loss) attributable to Adient $ 27  $ (335)
Net income adjustments:
EBIT adjustments total - see table (a) & (b) 19  377 
Tax impact of EBIT adjustments and other tax items - see table (d) (6) 15 
Pension actuarial loss — 
Write off of deferred financing costs upon repurchase of debt — 
Impact of adjustments on noncontrolling interests (6)
(1) (1)
Net income adjustments total 14  393 
Adjusted net income attributable to Adient $ 41  $ 58 

Refer to the Footnote Addendum for footnote explanations.


(d) Adjusted income tax expense and effective tax rate

The following table reconciles income before income taxes to adjusted income before income taxes, reconciles income tax expense to adjusted income tax expense and presents the related effective tax rate and adjusted effective tax rate:

Three months ended March 31,
2026 2025
(in millions, except effective tax rate) Income before income taxes Income tax expense (benefit) Effective tax rate Income before income taxes Income tax expense (benefit) Effective tax rate
As reported $ 76  $ 32  42.1  % $ (265) $ 48  (18.1) %
Adjustments
EBIT adjustments - see table (a) & (b) 19  15.8  % 377  16  4.2  %
Tax audit closures and statute expirations —  nm —  nm
UTP establishments and interest —  (2) nm —  (11) nm
NOL DTA adjustments —  —  nm —  (19) nm
Pension actuarial loss —  —  % —  —  nm
Net financing charges —  —  nm —  —  %
Other —  nm —  (2) nm
Subtotal of adjustments 21  28.6  % 379  (15) (4.0) %
As adjusted $ 97  $ 38  39.2  % $ 114  $ 33  28.9  %

nm - not meaningful




Appendix
Page 9

(e) Adjusted diluted earnings per share

The following table shows the calculation of diluted earnings per share on an adjusted basis:

Three Months Ended
March 31,
(in millions, except per share data) 2026 2025
Numerator:
Adjusted net income attributable to Adient - see table (c) $ 41  $ 58 
Denominator:
Basic weighted average shares outstanding 78.4  84.0 
Effect of dilutive securities:
Unvested restricted stock and unvested performance share awards 0.9  0.1 
Diluted weighted average shares outstanding 79.3  84.1 
Adjusted diluted earnings per share $ 0.52  $ 0.69 


The following table reconciles diluted earnings (loss) per share as reported to adjusted diluted earnings per share (see table (c) for corresponding dollar amounts):

Three Months Ended
March 31,
2026 2025
Diluted earnings (loss) per share as reported $ 0.34  $ (3.99)
EBIT adjustments total 0.24  4.49 
Tax impact of EBIT adjustments and other tax items (0.08) 0.18 
Pension actuarial loss 0.03  — 
Write off of deferred financing costs upon repurchase of debt —  0.02 
Impact of adjustments on noncontrolling interests (0.01) (0.01)
Adjusted diluted earnings per share $ 0.52  $ 0.69 


(f) Adjusted equity income

The following table reconciles equity income to adjusted equity income:
Three Months Ended
March 31,
(in millions) 2026 2025
Equity income $ 13  $ 18 
Equity income adjustments:
Restructuring charges at affiliates — 
Non-recurring loss at affiliates — 
Equity income adjustments total
Adjusted equity income $ 14  $ 19 




Appendix
Page 10

(g) Adjusted interest expense

The following table reconciles net financing charges to adjusted net financing charges:

Three Months Ended
March 31,
(in millions) 2026 2025
Net financing charges $ 48  $ 48 
Interest expense adjustments:
Write off of deferred financing costs upon repurchase of debt —  (2)
Interest expense adjustments total —  (2)
Adjusted net financing charges $ 48  $ 46 

(h) Free cash flow

The following table reconciles cash from operating activities to free cash flow:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions) 2026 2025 2026 2025
Operating cash flow $ 81  $ (45) $ 161  $ 64 
Capital expenditures (73) (45) (138) (109)
Free cash flow $ $ (90) $ 23  $ (45)


The following table reconciles adjusted EBITDA to free cash flow:

Three Months Ended
March 31,
Six Months Ended
March 31,
(in millions) 2026 2025 2026 2025
Adjusted EBITDA $ 223  $ 233  $ 430  $ 429 
Adjusted equity income (14) (18) (43) (39)
Dividends from partially owned affiliates 28  46  28  52 
Restructuring (cash) (19) (33) (38) (67)
Working capital (79) (207) (40) (146)
Interest paid (43) (33) (97) (87)
Cash taxes (54) (24) (74) (39)
Other 39  (9) (5) (39)
Capital expenditures (73) (45) (138) (109)
Free cash flow $ $ (90) $ 23  $ (45)

During the second quarter of fiscal 2026, Adient experienced higher operating cash flows resulting from certain commercial and derivative transactions approximating $90 million, which are expected to be settled and paid in the third quarter of fiscal 2026.










Appendix
Page 11



(i) & (j) Net debt and net leverage ratio

The following table presents calculations of net debt and net leverage ratio:

March 31, September 30,
(in millions) 2026 2025
Numerator:
Short-term debt $ —  $
Current portion of long-term debt
Long-term debt 2,379  2,386 
Total debt 2,388  2,397 
Less: cash and cash equivalents 831  958 
Net debt $ 1,557  $ 1,439 
Denominator:
Adjusted EBITDA - last four quarters
Q1 2025 na $ 196 
Q2 2025 na 233 
Q3 2025 226  226 
Q4 2025 226  226 
Q1 2026 207  na
Q2 2026 - see table (a) & (b) 223  na
Last four quarters $ 882  $ 881 
Net leverage ratio 1.77 1.63


Appendix
Page 12

Footnote Addendum

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and one-time asset impairments related
to restructuring activities. During the three months ended March 31, 2025 a goodwill impairment charge of $333 million was recorded in EMEA.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities:

Three Months Ended
March 31,
(in millions) 2026 2025
Restructuring related charges $ (5) $ (5)
Restructuring charges at affiliates (1) — 
$ (6) $ (5)

(5) Other items include:

Three Months Ended
March 31,
(in millions) 2026 2025
Non-recurring reserve release $ $ — 
Transaction costs (1) — 
Consulting costs associated with strategic planning —  (8)
Non-recurring loss at an affiliate —  (1)
$ $ (9)

(6) Reflects the impact of adjustments, primarily purchase accounting amortization on noncontrolling interests.